Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512623003983 |
| _version_ | 1827582761513254912 |
|---|---|
| author | Donglin Zhang, BA Kimberly Sable, MD Allison Miller, MD Molly Hinshaw, MD Timothy Schmidt, MD Bridget E. Shields, MD |
| author_facet | Donglin Zhang, BA Kimberly Sable, MD Allison Miller, MD Molly Hinshaw, MD Timothy Schmidt, MD Bridget E. Shields, MD |
| author_sort | Donglin Zhang, BA |
| collection | DOAJ |
| first_indexed | 2024-03-08T22:56:19Z |
| format | Article |
| id | doaj.art-33fcb48ed34c474da34f6d0fffb1c3a0 |
| institution | Directory Open Access Journal |
| issn | 2352-5126 |
| language | English |
| last_indexed | 2024-03-08T22:56:19Z |
| publishDate | 2023-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD Case Reports |
| spelling | doaj.art-33fcb48ed34c474da34f6d0fffb1c3a02023-12-16T06:07:56ZengElsevierJAAD Case Reports2352-51262023-12-01427883Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulinDonglin Zhang, BA0Kimberly Sable, MD1Allison Miller, MD2Molly Hinshaw, MD3Timothy Schmidt, MD4Bridget E. Shields, MD5Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, WisconsinDepartment of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, WisconsinDepartment of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, WisconsinDepartment of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, WisconsinDepartment of Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WisconsinDepartment of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; Correspondence to: Bridget E. Shields, MD, Department of Dermatology, University of Wisconsin School of Medicine and Public Health, 1 S Park St, 7th Floor, Madison, WI 53715.http://www.sciencedirect.com/science/article/pii/S2352512623003983cutaneous mucinosisgranulomatous scleromyxedemaJAK inhibitorsclerodermoid lichen myxedematosusscleromyxedema |
| spellingShingle | Donglin Zhang, BA Kimberly Sable, MD Allison Miller, MD Molly Hinshaw, MD Timothy Schmidt, MD Bridget E. Shields, MD Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin JAAD Case Reports cutaneous mucinosis granulomatous scleromyxedema JAK inhibitor sclerodermoid lichen myxedematosus scleromyxedema |
| title | Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin |
| title_full | Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin |
| title_fullStr | Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin |
| title_full_unstemmed | Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin |
| title_short | Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin |
| title_sort | granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib dapsone and intravenous immunoglobulin |
| topic | cutaneous mucinosis granulomatous scleromyxedema JAK inhibitor sclerodermoid lichen myxedematosus scleromyxedema |
| url | http://www.sciencedirect.com/science/article/pii/S2352512623003983 |
| work_keys_str_mv | AT donglinzhangba granulomatousvariantofscleromyxedemasuccessfullytreatedwithtopicalruxolitinibdapsoneandintravenousimmunoglobulin AT kimberlysablemd granulomatousvariantofscleromyxedemasuccessfullytreatedwithtopicalruxolitinibdapsoneandintravenousimmunoglobulin AT allisonmillermd granulomatousvariantofscleromyxedemasuccessfullytreatedwithtopicalruxolitinibdapsoneandintravenousimmunoglobulin AT mollyhinshawmd granulomatousvariantofscleromyxedemasuccessfullytreatedwithtopicalruxolitinibdapsoneandintravenousimmunoglobulin AT timothyschmidtmd granulomatousvariantofscleromyxedemasuccessfullytreatedwithtopicalruxolitinibdapsoneandintravenousimmunoglobulin AT bridgeteshieldsmd granulomatousvariantofscleromyxedemasuccessfullytreatedwithtopicalruxolitinibdapsoneandintravenousimmunoglobulin |